Robert M Snapka

The Sv40 Replicon Model for Analysis of Anticancer Drugs

• Gebundenes Buch

Produktbeschreibung

This volume of the Biotechnology Intelligence Unit series reviews the history of SV40 as a mammalian replicon model and covers the techniques used to analyze viral DNA replication.

Produktdetails

• Verlag: Elsevier Science
• Seitenzahl: 200
• Erscheinungstermin: 3. April 1996
• Englisch
• Abmessung: 261mm x 185mm x 18mm
• Gewicht: 780g
• ISBN-13: 9780126536300
• ISBN-10: 0126536309
• Artikelnr.: 21308286

Autorenporträt

Dr. Snapka is an associate professor of Radiology at The Ohio State University, teaching courses in Radiation Biology, DNA Tumor Viruses, Drug Resistance, and Genetic Instability. Dr. Snapka earned his B.S. in Biology and M.S. in Chemistry at North Texas State University. He earned his Ph.D. at the University of California, Irvine and worked as a Research Fellow at the University of California, Berkeley and Massachusetts Institute of Technology. He is the author of over 35 article in refereed journals and is currently conducting research in anticancer drug resistance and drug discovery.

Inhaltsangabe

R.M. Snapka
Papovavirus Models for Mammalian Replicons.R.M. Snapka
Analysis of SV40 DNA Replication Intermediates.R.M. Snapka
Catastrophic Failure of DNA Replication Forks: Structural and RecombinationalPathways. R.M. Snapka and E.F. Yamasaki
Topoisomerase II and the Termination of DNA Replication.R.M. Snapka
DNA Damaging Agents.R.M. Snapka
C.A. Ferrar
N.-J. Sun
and J.M. Cassady
Drug Discovery and Evaluation with SV40.L.H. Malkas
Simian Virus 40 (SV40) in Vitro DNA Replication: A Potential Model for Studying Anticancer Drug Action.R.M. Snapka and P.A. Permana
SV40 Circular Oligomer Series: Normal and Abnormal DNA Replication.Subject Index.